Company Overview
Snapshot
Founded in May 2024 by Dr. Michal and Ofra Benny, CultivO2 operates with 1-10 employees. The company has secured funding across one round from one investor, Fresh Start. This seed funding round in May 2024 highlights early investor confidence in its bio convergence platform for cultured meat production.
Business overview
CultivO2 is developing a bio convergence platform for the autonomic culture of animal tissue, aiming to reduce costs and enhance the scalability of cultured meat production. Its core technology utilizes photosynthetic microalgae to create a live oxygen-producing biomaterial that continuously excretes oxygen, growth factors, and glucose, while consuming toxic by-products. This symbiotic recycling system supports animal cell production for the food industry, potentially eliminating the need for traditional bioreactors and minimizing media requirements. The company targets the agriculture and food and industrial manufacturing sectors, with applications in low-cost cultured meat production, advanced tissue culture methods, and algae-based nutritional platforms.
Log in to access full profile ›Company Intelligence Q&A
- When was CultivO2 founded?
- CultivO2 was founded in May 2024.
- Who are the founders of CultivO2?
- The founders of CultivO2 are Dr. Michal and Ofra Benny.
- What is CultivO2's primary sector?
- CultivO2's primary sector is Agriculture & Food Technologies, specifically focusing on Food Tech and Novel Food & Ingredients.
- What is CultivO2's core technology?
- CultivO2's core technology involves a bio convergence platform that uses photosynthetic microalgae to create a symbiotic recycling system for culturing animal tissue, supporting the production of animal-based protein for the food industry.